Granger D N, McCord J M, Parks D A, Hollwarth M E
Gastroenterology. 1986 Jan;90(1):80-4. doi: 10.1016/0016-5085(86)90078-8.
Previous reports indicate that allopurinol, a xanthine oxidase inhibitor, largely prevents the injury produced by reperfusion of ischemic tissues. In order to further assess the role of xanthine oxidase in ischemia-reperfusion injury, we examined the influence of another inhibitor of the enzyme (pterin aldehyde) on the increased vascular permeability produced by intestinal ischemia. Vascular permeability estimates in autoperfused segments of cat ileum were derived from the relationship between lymph-to-plasma protein concentration ratio and lymph flow. One hour of intestinal ischemia increased vascular permeability to 0.43 +/- 0.02 from a control (nonischemic) value of 0.08 +/- 0.005. In ischemic ileal segments pretreated with purified pterin aldehyde, vascular permeability increased to only 0.15 +/- 0.02. Pretreatment with commercially prepared folic acid, which is contaminated with pterin aldehyde, also attenuated the ischemia-induced increase in vascular permeability (0.16 +/- 0.04). These findings support the hypothesis that xanthine oxidase is a major source of oxygen-free radicals produced during reperfusion of the ischemic small bowel.
先前的报告表明,黄嘌呤氧化酶抑制剂别嘌呤醇在很大程度上可预防缺血组织再灌注所产生的损伤。为了进一步评估黄嘌呤氧化酶在缺血再灌注损伤中的作用,我们研究了该酶的另一种抑制剂(蝶呤醛)对肠缺血所致血管通透性增加的影响。猫回肠自身灌注段的血管通透性评估值源自淋巴与血浆蛋白浓度比和淋巴流量之间的关系。肠缺血1小时使血管通透性从对照(非缺血)值0.08±0.005增加到0.43±0.02。在用纯化的蝶呤醛预处理的缺血回肠段中,血管通透性仅增加到0.15±0.02。用含有蝶呤醛的市售叶酸预处理也减弱了缺血诱导的血管通透性增加(0.16±0.04)。这些发现支持了这样的假说,即黄嘌呤氧化酶是缺血小肠再灌注期间产生的氧自由基的主要来源。